ISEO – Inaugural Conference July 22nd & 23rd 2026 - organized by DKFZ

Session

Oral Session 8

Jul 23, 2026, 3:15 PM

Heidelberg Congress Center

Description

Chairs: Helen Croker & Katharina Graf

189. 12-Weeks of Precision Exercise Reduces Frailty by Increasing Fitness in Chronic Lymphocytic Leukaemia: A Randomised Controlled Trial

Ellie Miles (University of Surrey)

7/23/26, 3:15 PM

3 - Talk

Purpose: Chronic lymphocytic leukaemia (CLL), whether treatment-naïve (TN) or being treated (TRE), increases frailty risk. Underlying this is an abnormal reduction in aerobic fitness and strength. Previous exercise studies have failed to improve aerobic fitness, likely due to their generalised approach. We aimed to evaluate the impact of a 12-week precision exercise intervention in adults with...

301. Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors with Persistent Fatigue- A Randomized Controlled Trial (the REFUEL-trial)

Synne-Kristin Hoffart Bøhn (Oslo University Hospital)

7/23/26, 3:30 PM

3 - Talk

Background: Persistent fatigue is a prevalent, complex and distressing late effect after cancer, but few treatment options exist. We tested the effect of a multidisciplinary intervention on fatigue in lymphoma survivors with persistent fatigue (≥6 months).
Patients and methods: Survivors mean 7 years post-treatment were randomly assigned to usual care (n=75) or a 12-week multidisciplinary...

203. Improving health outcomes after endometrial cancer: the ACUMEN trial

Eliza Macdonald (UNSW Sydney)

7/23/26, 3:45 PM

3 - Talk

Introduction
Metabolic dysfunction is a key driver of Endometrial cancer (EC), and contributes to disproportionately high rates of cardiometabolic disease, cardiovascular mortality, EC recurrence, and a two-fold reduction in overall survival after EC. Exercise imparts physiological adaptations including improved cardiorespiratory fitness (CRF), body composition, and glucose handling that...

87. Specific exercise is more effective than medication – prevention and treatment of Chemotherapy-induced peripheral neuropathy – State of the art

Fiona Streckmann (Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland; Department of Oncology, University Hospital Basel, Basel, Switzerland)

7/23/26, 4:00 PM

3 - Talk

Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant side-effect that not only diminishes patients’ quality of life but can also impact their medical treatment and survival. The side effects are burdensome, difficult to treat, and often become chronic. Currently, there are no effective pharmacological treatment options available. A meta-analysis has...

331. Effects of supervised aerobic and resistance exercise on quality of life in men with metastatic prostate cancer: Results from the INTERVAL-GAP4 trial

Ki-Yong An (University of Alberta)

7/23/26, 4:15 PM

3 - Talk

Background: Many studies demonstrate exercise is an effective adjunct therapy for prostate cancer, however, limited research has focused on metastatic prostate cancer. The current study examined the effects of supervised exercise on quality of life (QoL) in men with advanced prostate cancer.
Methods: In this multinational, randomized controlled trial, men with metastatic prostate cancer were...